The role of constitutively activated STAT3 in B16 melanoma cells

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Constitutively activated STAT3 is found frequently in a wide variety of human tumors, including melanoma. Moreover, constitutive STAT3 activation actively participates in tumor formation and progression, making STAT3 an attractive target for cancer therapy. We report here that in murine B16 melanoma cells, which have been previously shown to express constitutively active STAT3, the expression of a mutant form of STAT3 with the canonical tyrosine phosphorylation site (residue 705) mutated to phenylanaine has dominant-negative properties (STAT3-DN). STAT3-DN inhibits STAT3 tyrosine phosphorylation and STAT3-dependent DNA binding activity. Most importantly, STAT3-DN expression in B16 cells inhibits their invasiveness, as well as their melanogenesis by down-regulation of tyrosinase mRNA and protein expression as well as tyrosinase activity. These results suggest that STAT3 signaling plays a critical role in regulating melanoma behavior, and may represent a druggable target for melanoma therapy.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalInternational Journal of Interferon, Cytokine and Mediator Research
Volume2
Issue number1
StatePublished - Apr 30 2010

Fingerprint

Experimental Melanomas
Melanoma
Monophenol Monooxygenase
Tyrosine
Phosphorylation
Neoplasms
Down-Regulation
Messenger RNA
DNA
Therapeutics
Proteins

All Science Journal Classification (ASJC) codes

  • Immunology
  • Immunology and Allergy

Cite this

@article{f6016d7e82da4f2f8e622eaa91688a50,
title = "The role of constitutively activated STAT3 in B16 melanoma cells",
abstract = "Constitutively activated STAT3 is found frequently in a wide variety of human tumors, including melanoma. Moreover, constitutive STAT3 activation actively participates in tumor formation and progression, making STAT3 an attractive target for cancer therapy. We report here that in murine B16 melanoma cells, which have been previously shown to express constitutively active STAT3, the expression of a mutant form of STAT3 with the canonical tyrosine phosphorylation site (residue 705) mutated to phenylanaine has dominant-negative properties (STAT3-DN). STAT3-DN inhibits STAT3 tyrosine phosphorylation and STAT3-dependent DNA binding activity. Most importantly, STAT3-DN expression in B16 cells inhibits their invasiveness, as well as their melanogenesis by down-regulation of tyrosinase mRNA and protein expression as well as tyrosinase activity. These results suggest that STAT3 signaling plays a critical role in regulating melanoma behavior, and may represent a druggable target for melanoma therapy.",
author = "Chuan Yang and Meiyun Fan and Slominski, {Andrzej T.} and Junming Yue and Lawrence Pfeffer",
year = "2010",
month = "4",
day = "30",
language = "English (US)",
volume = "2",
pages = "1--7",
journal = "International Journal of Interferon, Cytokine and Mediator Research",
issn = "1179-139X",
publisher = "Dove Medical Press Ltd.",
number = "1",

}

TY - JOUR

T1 - The role of constitutively activated STAT3 in B16 melanoma cells

AU - Yang, Chuan

AU - Fan, Meiyun

AU - Slominski, Andrzej T.

AU - Yue, Junming

AU - Pfeffer, Lawrence

PY - 2010/4/30

Y1 - 2010/4/30

N2 - Constitutively activated STAT3 is found frequently in a wide variety of human tumors, including melanoma. Moreover, constitutive STAT3 activation actively participates in tumor formation and progression, making STAT3 an attractive target for cancer therapy. We report here that in murine B16 melanoma cells, which have been previously shown to express constitutively active STAT3, the expression of a mutant form of STAT3 with the canonical tyrosine phosphorylation site (residue 705) mutated to phenylanaine has dominant-negative properties (STAT3-DN). STAT3-DN inhibits STAT3 tyrosine phosphorylation and STAT3-dependent DNA binding activity. Most importantly, STAT3-DN expression in B16 cells inhibits their invasiveness, as well as their melanogenesis by down-regulation of tyrosinase mRNA and protein expression as well as tyrosinase activity. These results suggest that STAT3 signaling plays a critical role in regulating melanoma behavior, and may represent a druggable target for melanoma therapy.

AB - Constitutively activated STAT3 is found frequently in a wide variety of human tumors, including melanoma. Moreover, constitutive STAT3 activation actively participates in tumor formation and progression, making STAT3 an attractive target for cancer therapy. We report here that in murine B16 melanoma cells, which have been previously shown to express constitutively active STAT3, the expression of a mutant form of STAT3 with the canonical tyrosine phosphorylation site (residue 705) mutated to phenylanaine has dominant-negative properties (STAT3-DN). STAT3-DN inhibits STAT3 tyrosine phosphorylation and STAT3-dependent DNA binding activity. Most importantly, STAT3-DN expression in B16 cells inhibits their invasiveness, as well as their melanogenesis by down-regulation of tyrosinase mRNA and protein expression as well as tyrosinase activity. These results suggest that STAT3 signaling plays a critical role in regulating melanoma behavior, and may represent a druggable target for melanoma therapy.

UR - http://www.scopus.com/inward/record.url?scp=77953467644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953467644&partnerID=8YFLogxK

M3 - Article

VL - 2

SP - 1

EP - 7

JO - International Journal of Interferon, Cytokine and Mediator Research

JF - International Journal of Interferon, Cytokine and Mediator Research

SN - 1179-139X

IS - 1

ER -